3/5
07:43 am
amph
Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) is now covered by analysts at JPMorgan Chase & Co.. They set an "overweight" rating and a $60.00 price target on the stock.
Low
Report
Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) is now covered by analysts at JPMorgan Chase & Co.. They set an "overweight" rating and a $60.00 price target on the stock.
3/5
06:18 am
amph
Rating for AMPH
Low
Report
Rating for AMPH